Ultra high-speed optical coherence tomography (OCT) offers the potential to follow minute changes in patients with various pathologies. Johannes de Boer, PhD, the Wellman Center of Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, reviewed the principles of OCT and the status of ultra high-speed OCT.
Stability of technology is important when dealing with patients who have a progressive disease, said Balwantray Chauhan, PhD, professor and director of research, Department of Ophthalmology, Dalhousie University, Halifax, Nova Scotia.
Second-harmonic signaling with the femtosecond laser (IntraLase, Advanced Medical Optics) can be used to probe corneal structure and function. In combination with laser-induced optical breakdown, it also can help create three-dimensional measures of elasticity as well as provide details on the biomechanical properties of the eye, according to James V. Jester, PhD, professor of ophthalmology, University of California, Irvine.
Mitochondrial oxidative stress induced by translocation of inducible nitric oxide synthetase (iNOS) from the cytosol into the photoreceptor mitochondria appears to be a primary event leading to photoreceptor damage in experimental autoimmune uveitis (EAU), said Narsing A. Rao, MD, professor of ophthalmology, and director, ophthalmic pathology laboratory and uveitis service, University of Southern California, Los Angeles.
Optical coherence tomography (OCT) continues to evolve and improve, offering clinicians more detailed information on the status of patients' eyes. Joel Shuman, MD, University of Pennsylvania Medical Center Eye Center, University of Pittsburgh School of Medicine, and a co-inventor of OCT, reviewed the technology and contrasted the first-generation technology with spectral domain technology.
The "perfect storm" in health care is on its way, according to Paul Lee, MD, JD, Duke University, Durham, NC, as he described areas where research and potential paradigm changes can contribute to meeting society's needs to enhance vision, maintain wellness, and prevent vision loss. Dr. Lee delivered a keynote address entitled "Future challenges and opportunities in eye research and the aging population" during The Association for Research in Vision and Ophthalmology (ARVO)/Alcon keynote session Sunday evening.
There is value in studying a model of human disease that is not a carbon copy, said Jayakrishna Ambati, MD, associate professor, School of Medicine, and vice chairman, Department of Ophthalmology and Visual Sciences, University of Kentucky, Lexington.
Visual field screening is an indispensable tool and a prerequisite for proper disease management
Epi-LASIK is safer for patients; it offers a lower risk of ectasia, fewer serious complications and better contrast sensitivity, according to Robert J. Mitchell.
Canaloplasty can offer a number of advantages over other techniques... by enhancing aqueous outflow without creating a bleb
Identifying the bottlenecks that are preventing effective management of neovascular AMD.
In December 2006, the Swiss city of Geneva played host to the very first European glaucoma resident's course, designed for ophthalmic residents seeking the necessary skills for the diagnosis and therapy of glaucoma.
Stating the case for the use of preservative-free medications in glaucoma patients with ocular surface disease.
Welcome to this, the glaucoma special issue of Ophthalmology Times Europe. This month we aim to give you a taste of events from the International Glaucoma Society meeting, which was held in Athens in March. If you were not able to make it, we hope this section will allow you to feel as though you did not miss out on some of the important presentations.
Athens played host to the sixth annual International Glaucoma Society (IGS) congress, which ran from 28-31 March. Attended by more than 2,650 participants from around the world, the meeting earned the title of the most attended international glaucoma meeting ever held.
[Ex-PRESS] should be used as a second treatment option or as a first-line option in complicated cases of glaucoma
Bausch & Lomb has received new technology intraocular lens (NTIOL) status for the regular and violet-filtering models of its SofPort Advanced Optics intraocular lenses (IOLs).
Optometrists display a good ability to correctly identify and manage patients in busy accident and emergency (A&E) departments, according to a report published in the April issue of the British Journal of Ophthalmology.
The growing popularity of LASIK and other new innovations in refractive surgery is set to push sales in the global market from $1.3 billion in 2006 to an estimated $4.5 billion in 2009, according to market research firm Kalorama Information.
Assessing povidone-iodine as method for preventing endophthalmitis.
The FDA has denied Eli Lilly's appeal of the agency's ruling requiring it to conduct an additional three-year study of ruboxistaurin mesylate (Arxxant) before it can be approved for treating diabetic retinopathy (DR).
Advanced Medical Optics (AMO) has completed its acquisition of IntraLase Corp.
The growing popularity of LASIK and other new innovations in refractive surgery is set to push sales in the global market from $1.3 billion in 2006 to an estimated $4.5 billion in 2009, according to market research firm Kalorama Information.
Potentia Pharmaceuticals has announced that it is entering the clinical phase of development for POT-4, its lead drug candidate for the treatment of age-related macular degeneration (AMD).
The Ziemer group is to assume all worldwide marketing, sales and support duties for AMO's Amadeus II automated microkeratome.
Digital imaging technology, used during primary care visits, can significantly improve screening rates for diabetic retinopathy, according to a report published in the March issue of Diabetes Care.
Non-infectious endophthalmitis is observed more frequently after injections of triamcinolone acetonide that contain preservatives (PTA) than after injections of preservative-free triamcinolone acetonide (PFTA), according to a study published online ahead of print in the British Journal of Ophthalmology.
Azithromycin is just as effective and safe as tobramycin for the treatment of purulent bacterial conjunctivitis, according to a report published in the April issue of the British Journal of Ophthalmology.
A study published in the March issue of Ophthalmology, has found that many young and middle-aged people of Chinese ancestry who are told they have glaucoma may actually be misdiagnosed. These patients who do not show disease progression may, in fact, have glaucoma-like symptoms caused by myopia.
Regeneron Pharmaceuticals and Bayer Healthcare have announced positive preliminary data from a Phase II randomized study of the VEGF Trap-Eye treatment for wet age-related macular degeneration (AMD).
